Dr Simon Russell is a Consultant Clinical Oncologist based at Addenbrooke's Hospital in Cambridge.

Dr Russell trained at Guy’s and St Thomas’ Hospitals London where he was awarded a first class honours degree, distinction and several academic prizes. Following general medical training at Guy’s Hospital he undertook his formal oncology training at Addenbrooke’s Hospital Cambridge and University College Hospital London. He also spent a year with the Institute of Urology at the Middlesex Hospital. During his training he was awarded the Royal College of Radiology Medal for the FRCR examination.

Dr Russell works closely with his surgical colleagues, employing the latest techniques using radiotherapy (including brachytherapy), hormonal therapy, chemotherapy and biological therapy to treat urological cancers (prostate and bladder), breast cancer and skin cancers. With his colleagues at Addenbrooke’s Hospital he has brought state of the art radiotherapy such as Intensity Modulated Radiotherapy (IMRT), Image Guided Radiotherapy (IGRT) and prostate Brachytherapy into clinical practice.

Dr Russell is a Member of the Royal College of Radiologists, British Uro-Oncology Group (Secretary) and the Medical Protection Society.

Dr Kate Fife is a Consultant Clinical Oncologist based at Addenbrooke's Hospital in Cambridge. She was appointed in 2001.

Dr Fife trained in medicine at St George’s Hospital in London and went on to train in oncology at the Royal Marsden Hospital. She carried out clinical research in HIV related malignancies whilst a research fellow at Chelsea and Westminster, and Charing Cross Hospitals and completed an MD in angiogenesis related laboratory research in 1998. She completed her oncology training at the Hammersmith Hospital. Subsequently she was a locum Consultant and research fellow at the Sydney Cancer Centre and Sydney Melanoma Unit, carrying out further laboratory and clinical research.

Together with Prof Tim Eisen and Dr Athena Matakidou, she runs a large research focussed renal cancer clinic, seeing approximately 130 new patients per year, making it one of the largest specialist centres for this cancer in the UK.  Her other interests are skin malignancies and lung cancer. She treats basal cell and squamous cell cancers of the skin and metastatic melanoma with radiotherapy and patients with rare skin cancers, cutaneous lymphomas and Kaposi’s sarcoma. She is also interested in training and is an educational supervisor.

She is a member of the National Cancer Research Institute Renal Cancer Studies Group and has a frequent attendance and presentations at National and International meetings.